Evidence map›Paper›PMID 23977374›Full record

ArticlePloS one2013

A reinforcing circuit action of extrasynaptic GABAA receptor modulators on cerebellar granule cell inhibition.

Vijayalakshmi Santhakumar, Pratap Meera, Movses H Karakossian, Thomas S Otis

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Glutamate Delta 1 Receptor in Synapses, Circuits, and Disease.The European journal of neuroscience · 2026
    Review
  2. A Role for GABATremor and other hyperkinetic movements (New York, N.Y.) · 2024
    Article
  3. Article
  4. Alcohol and Ganaxolone Suppress Tremor via Extra-Synaptic GABATremor and other hyperkinetic movements (New York, N.Y.) · 2023
    Article
  5. Direction of action of presynaptic GABAJournal of neurophysiology · 2019
    Article
  6. GABANeuropharmacology · 2018
    Review
  7. The Cerebellar GABAHandbook of experimental pharmacology · 2018
    Article
  8. Suppression of Harmaline Tremor by Activation of an Extrasynaptic GABATremor and other hyperkinetic movements (New York, N.Y.) · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Vijayalakshmi SanthakumarDepartment of Neurobiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America. santhavi@njms.rutgers.edu
Pratap Meera
Movses H Karakossian
Thomas S Otis
University of California, Los Angeles · USRutgers, The State University of New Jersey · US

Funding

ZINC AND GABAA RECEPTOR PLASTICITYP01NS035985 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MODY, ISTVAN · 1998 to 2009
$7.9M
Perisomatic Inhibitory Network Dysfunction in Neurological DiseaseR01NS069861 · NINDS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI SANTHAKUMAR, VIJAYALAKSHMI · 2011 to 2022
$3.4M
Novel optical approaches to study alcohol actions on GABA receptorsR21AA019737 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI OTIS, THOMAS S · 2010 to 2011
$405k
NIAAA NIH HHS R21 AA019737NIAAA NIH HHS R21 AA19737NINDS NIH HHS P01 NS035985NINDS NIH HHS P01 NS35985NINDS NIH HHS R01 NS069861
6 · The paper itself

Abstract

GABAA receptors (GABARs) are the targets of a wide variety of modulatory drugs which enhance chloride flux through GABAR ion channels. Certain GABAR modulators appear to acutely enhance the function of δ subunit-containing GABAR subtypes responsible for tonic forms of inhibition. Here we identify a reinforcing circuit mechanism by which these drugs, in addition to directly enhancing GABAR function, also increase GABA release. Electrophysiological recordings in cerebellar slices from rats homozygous for the ethanol-hypersensitive (α6100Q) allele show that modulators and agonists selective for δ-containing GABARs such as THDOC, ethanol and THIP (gaboxadol) increased the frequency of spontaneous inhibitory postsynaptic currents (sIPSCs) in granule cells. Ethanol fails to augment granule cell sIPSC frequency in the presence of glutamate receptor antagonists, indicating that circuit mechanisms involving granule cell output contribute to ethanol-enhancement of synaptic inhibition. Additionally, GABAR antagonists decrease ethanol-induced enhancement of Golgi cell firing. Consistent with a role for glutamatergic inputs, THIP-induced increases in Golgi cell firing are abolished by glutamate receptor antagonists. Moreover, THIP enhances the frequency of spontaneous excitatory postsynaptic currents in Golgi cells. Analyses of knockout mice indicate that δ subunit-containing GABARs are required for enhancing GABA release in the presence of ethanol and THIP. The limited expression of the GABAR δ subunit protein within the cerebellar cortex suggests that an indirect, circuit mechanism is responsible for stimulating Golgi cell GABA release by drugs selective for extrasynaptic isoforms of GABARs. Such circuit effects reinforce direct actions of these positive modulators on tonic GABAergic inhibition and are likely to contribute to the potent effect of these compounds as nervous system depressants.

Indexed as

Action PotentialsAnimalsCerebellumEthanolExcitatory Amino Acid AntagonistsExcitatory Postsynaptic PotentialsGABA-A Receptor Agonistsgamma-Aminobutyric AcidGlutamatesInhibitory Postsynaptic PotentialsIon Channel GatingIsoxazolesMice, Inbred C57BLNeural InhibitionNeuronsProtein SubunitsEthanolExcitatory Amino Acid AntagonistsGABA-A Receptor Agonistsgaboxadolgamma-Aminobutyric AcidGlutamatesIsoxazolesProtein SubunitsReceptors, GABA-AReceptors, Glutamate

Identifiers

PMID23977374
PMCPMC3747091
OpenAlexW1988383440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.